Exploratory Development of a Prognostic Model for Coronary Artery Disease Utilizing CT-FFR Derived Functional Duke

Li-Na Ouyang1, Rui Wang1, Qian Wu1

  • 1Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan 750003, China.

Academic Radiology
|December 6, 2024
PubMed

Insights

The functional Duke Jeopardy Score based on CT-FFR (fDJSCTA) is a strong predictor of major adverse cardiovascular events (MACE) in coronary artery disease (CAD) patients. This score improves risk assessment and clinical utility for prognostic evaluation in CAD.

Area of Science:

  • Cardiovascular Imaging and Intervention
  • Cardiac CT and Functional Assessment

Background:

  • Coronary artery disease (CAD) poses a significant risk for major adverse cardiovascular events (MACE).
  • Accurate prognostic tools are crucial for managing patients with CAD.
  • CT-derived fractional flow reserve (CT-FFR) offers functional insights into coronary stenosis.

Purpose of the Study:

  • To evaluate the prognostic value of the functional Duke Jeopardy Score based on CT-FFR (fDJSCTA).
  • To assess the ability of fDJSCTA in predicting MACE in patients with stable CAD.
  • To compare the predictive performance of fDJSCTA against existing scores and CT-FFR alone.

Main Methods:

  • A cohort of 894 patients with stable CAD undergoing CCTA were analyzed.
  • Patients were divided into training (70%) and validation (30%) sets.
  • Prognostic analysis utilized univariable and multivariable Cox regressions, with model performance assessed by AUC, NRI, and IDI.

Main Results:

  • Over a median follow-up of 33 months, 18.68% of patients experienced MACE.
  • Multivariate analysis identified fDJSCTA (HR: 4.68) as an independent predictor of MACE, outperforming DJSCTA (HR: 2.07).
  • fDJSCTA significantly improved risk re-stratification (NRI: 0.993) and predictive ability (IDI: 0.101) compared to CT-FFR and DJSCTA.

Conclusions:

  • The functional Duke Jeopardy Score based on CT-FFR (fDJSCTA) is the strongest predictor of MACE in this cohort.
  • A prediction model based on fDJSCTA demonstrates high discrimination, good calibration, and significant clinical utility.
  • fDJSCTA offers enhanced prognostic evaluation for patients with coronary artery disease.
Abstract